Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression
about
Chronic CSE treatment induces the growth of normal oral keratinocytes via PDK2 upregulation, increased glycolysis and HIF1α stabilizationSystemic VHL gene functions and the VHL diseaseHypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progressionAssociation between pharmaceutical support and basic science research on erythropoiesis-stimulating agentsRecombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitroLow-level laser therapy alleviates neuropathic pain and promotes function recovery in rats with chronic constriction injury: possible involvements in hypoxia-inducible factor 1α (HIF-1α).The effect of erythropoietin on normal and neoplastic cells.Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Erythropoietin after a century of research: younger than ever.The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis.Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.Functional erythropoietin autocrine loop in melanomaIron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinomaErythropoietin Receptor Antagonist Suppressed Ectopic Hemoglobin Synthesis in Xenografts of HeLa Cells to Promote Their DestructionPrognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.Clinicopathological characteristics of gynecological cancer associated with hypoxia-inducible factor 1α expression: a meta-analysis including 6,612 subjects.Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis.Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastomaErythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.Long-term results of radiation therapy oncology group 9903: a randomized phase 3 trial to assess the effect of erythropoietin on local-regional control in anemic patients treated with radiation therapy for squamous cell carcinoma of the head and necTissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomasEffect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysisMicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review.Expression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patients.Role of erythropoietin in cancer-related anaemia: a double-edged sword?Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway.RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives.Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8.Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells.Erythropoietin in thyroid cancer.Erythropoietin and co.: intrinsic structure and functional disorder.miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer.Impact of erythropoietin on the effects of irradiation under hypoxia.
P2860
Q24338864-26001D59-6BB3-4AEB-9D53-F3B3057153B8Q24605882-908D241F-B96A-4C75-971B-1418E9E9BA1AQ33382510-55FF7DC3-E2EC-4A61-A864-A54C8380E5DAQ34068226-06BE4867-0E56-4549-9F36-4571311A4498Q34107767-CACF8754-CCF5-4ECF-9F00-97896BEEFFEBQ34165022-D39D691C-119F-4C25-8508-1DA369A78C68Q34291437-5F1BFF4F-3349-4057-9631-2B20E382E56BQ34504572-73BBFA1A-8609-440F-8159-D382EEFFD7C3Q34606348-A39042A1-C550-4351-88D2-EC8AAF2A1E92Q34621874-4F4A7C9D-E82C-4840-AC5B-73F8AF266753Q34768481-58373021-759B-406F-8E6A-AB08022EBA43Q35083677-04968329-74A0-4311-AAA5-357A39D19F1CQ35388676-91C5FF1B-31DB-4A9A-8671-8EC4C4A9CD3FQ35404296-7F0F9BE3-2B27-46EF-A4D8-55F960C28526Q35432520-81616637-3B8C-426E-B141-B69B6546A223Q35619493-98B24B13-C682-4EE8-8F6D-4BFE6037AFD5Q35625509-66E84E5A-7FDE-495E-A578-B09D7B7C76F2Q35741127-B7D180BA-483D-4EB5-883E-CE84DE007B0FQ35839982-81596597-E213-498D-AE1C-BC8C7F111E1FQ35840006-A6626A69-3C8D-47A4-B146-9EBD336A9365Q36311491-068D71EA-BC0B-4A40-BF8A-8F31134DB3AEQ36366580-4D4AE3D5-298B-4CE9-B4D5-AA23FF06D90AQ36431079-35DD2026-60F9-4469-8FF7-6B467DB33315Q36494154-125790F1-CB5F-4431-9367-C364B0EF074DQ36610386-6B51B251-1D2B-4CCE-A121-1BB233B72A22Q36610552-4146F72A-79C5-48A2-98CD-A16CF3EC610DQ36612465-6AA5A024-8331-471F-9C80-C6C6854E3657Q36671852-54444B34-45B0-46F4-A5EA-14D388978ED9Q36718130-CBAB1365-1281-4A98-B77C-70BD9072B91FQ36854821-DB9DACF6-0C55-443C-884E-613A5EAFAF29Q37071262-3871F544-5C85-4138-9FBD-EE9635555781Q37151778-E025113E-3F91-4674-884B-20050296AB08Q37164573-ECB96357-1092-4D1A-AB99-00A7B4B2DB82Q37456976-A296C343-7503-4316-8A4C-7631CE567E40Q37587351-F95BAFB9-EBB2-4342-B2B1-D6849F72B08FQ38292589-19A269C8-BD1B-4D79-8005-85D9258522BDQ38437717-2C23CC62-2B8E-451E-A814-0940B9BB2B18Q39005050-971F9CEC-B73F-4DF2-A9EF-A3911866C4D2Q39480964-B0F34465-C889-46DD-8A82-91D3EDD1DC65Q39842379-5558D913-229E-4020-810B-1A6D2EF95195
P2860
Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@ast
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@en
type
label
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@ast
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@en
prefLabel
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@ast
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@en
P2093
P2860
P1476
Hypoxia-inducible erythropoiet ...... ogenesis and tumor progression
@en
P2093
Ahmed Mohyeldin
Ajay Verma
Cindy M McGrath
Huasheng Lu
John McBroom
Paul J Zhang
Suzhen Liu
P2860
P304
P356
10.1016/S0002-9440(10)64314-3
P407
P577
2003-06-01T00:00:00Z